Treatment of Refractory Babesia microti Infection with Atovaquone-Proguanil in an HIV-Infected Patient: Case Report
Open Access
- 15 December 2007
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 45 (12) , 1588
- https://doi.org/10.1086/523731
Abstract
A patient with acquired immune deficiency syndrome presented with babesiosis 6 months after presumed tick exposure. Despite initial treatment with azKeywords
This publication has 18 references indexed in Scilit:
- The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2006
- Resistance to Acute Babesiosis Is Associated with Interleukin-12- and Gamma Interferon-Mediated Responses and Requires Macrophages and Natural Killer CellsInfection and Immunity, 2003
- Cellular Immunity, but Not Gamma Interferon, Is Essential for Resolution ofBabesia microtiInfection in BALB/c MiceInfection and Immunity, 2002
- Babesiosis in humans: a treatment reviewExpert Opinion on Pharmacotherapy, 2002
- Exchange transfusion for malaria and babesia infectionTransfusion Medicine Reviews, 2002
- Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind studyThe Lancet, 2000
- Atovaquone and Azithromycin for the Treatment of BabesiosisNew England Journal of Medicine, 2000
- Persistent Parasitemia after Acute BabesiosisNew England Journal of Medicine, 1998
- Babesiosis in Patients with AIDS: A Chronic Infection Presenting as Fever of Unknown OriginClinical Infectious Diseases, 1996
- Treatment of babesiosis by red blood cell exchange in an HIV‐positive, splenectomized patientJournal of Clinical Apheresis, 1993